½ÃÀ庸°í¼­
»óǰÄÚµå
1459810

µ¶¼º °Ë»ç ¼­ºñ½º ½ÃÀå : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¹× ¿¹Ãø(2023-2031³â)

Toxicology Testing Services Market (In Vivo Method, In Vitro Method, and In Silico Method) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Transparency Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 201 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

µ¶¼º °Ë»ç ¼­ºñ½º ½ÃÀå - Á¶»ç¹üÀ§

TMRÀÇ ¼¼°è µ¶¼º °Ë»ç ¼­ºñ½º ½ÃÀå Á¶»ç º¸°í¼­´Â 2023³âºÎÅÍ 2031³â±îÁöÀÇ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ÁöÇ¥¿¡ ´ëÇÑ ±ÍÁßÇÑ ÅëÂû·ÂÀ» ¾ò±â À§ÇØ °ú°Å»Ó¸¸ ¾Æ´Ï¶ó ÇöÀçÀÇ ¼ºÀå µ¿Çâ°ú ±âȸ¸¦ Á¶»çÇß½À´Ï´Ù. ÀÌ º¸°í¼­´Â 2023³âÀ» ±âÁØ ¿¬µµ, 2031³âÀ» ¿¹Ãø ¿¬µµ·Î ÇÏ¿© 2017³âºÎÅÍ 2031³â±îÁö ¼¼°è µ¶¼º °Ë»ç ¼­ºñ½º ½ÃÀåÀÇ ¼öÀͰú ¿¹ÃøÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ 2023³âºÎÅÍ 2031³â±îÁö ¼¼°è µ¶¼º °Ë»ç ¼­ºñ½º ½ÃÀåÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR%)µµ Á¦½ÃÇÕ´Ï´Ù.

ÀÌ º¸°í¼­´Â ±¤¹üÀ§ÇÑ 1Â÷ Á¶»ç, KOL(Key Opinion Leader), ¾÷°è ¸®´õ ¹× ¿ÀÇǴϾð Á¦Á¶¾÷ü¿ÍÀÇ ÀÎÅͺä, ÁÖ¿ä ±â¾÷ÀÇ Á¦Ç° ÀÚ·á, ¿¬·Ê º¸°í¼­, º¸µµ ÀÚ·á, °ü·Ã ¹®¼­ µîÀ» ÅëÇØ µ¶¼º °Ë»ç ¼­ºñ½º ½ÃÀåÀ» ÆÄ¾ÇÇϱâ À§ÇÑ 2Â÷ Á¶»ç¸¦ ÅëÇØ ÀÛ¼ºµÇ¾ú½À´Ï´Ù. À» Âü°íÇß½À´Ï´Ù.

½ÃÀå ÇöȲ
2022³â ½ÃÀå ±Ô¸ð 347¾ï ´Þ·¯
2031³â ½ÃÀå °¡Ä¡ 557¾ï ´Þ·¯
CAGR 5.5%

ÀÌ º¸°í¼­´Â ¼¼°è µ¶¼º °Ë»ç ¼­ºñ½º ½ÃÀåÀÇ °æÀï ȯ°æÀ» Á¶»çÇß½À´Ï´Ù. ¼¼°è µ¶¼º °Ë»ç ¼­ºñ½º ½ÃÀå¿¡¼­ »ç¾÷À» Àü°³ÇÏ´Â ÁÖ¿ä ±â¾÷µéÀÌ È®ÀεǾúÀ¸¸ç, °¢ ±â¾÷µéÀº ´Ù¾çÇÑ ¼Ó¼ºÀ¸·Î ÇÁ·ÎÆÄÀϸµµÇ¾ú½À´Ï´Ù. ±â¾÷ °³¿ä, À繫 »óÅÂ, ÃÖ±Ù ½ÃÀå °³¹ß, SWOT´Â º» º¸°í¼­¿¡¼­ ¼Ò°³ÇÏ´Â ¼¼°è µ¶¼º °Ë»ç ¼­ºñ½º ½ÃÀåÀÇ ±â¾÷ ¼Ó¼ºÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå Á¶»çÀÇ ÀüÁ¦Á¶°Ç°ú Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à : ¼¼°è ½ÃÀå

Á¦4Àå ½ÃÀå °³¿ä

  • ½ÃÀå ¼¼ºÐÈ­
  • ½ÃÀå °³¿ä
  • ½ÃÀå ¿ªÇÐ
  • ¼¼°è ½ÃÀå ºÐ¼®°ú ¿¹Ãø, 2022³â-2031³â

Á¦5Àå ÁÖ¿ä ÀλçÀÌÆ®

  • ÆÄÀÌÇÁ¶óÀÎ ºÐ¼®
  • °Ë»ç À¯Çü ¸®½ºÆ®
  • ¼¼°è Áúȯ À¯º´·ü°ú ÀÌȯÀ², ÁÖ¿ä ±¹°¡º°
  • COVID-19 ÆÒµ¥¹Í »ê¾÷¿¡ ´ëÇÑ ¿µÇâ

Á¦6Àå ½ÃÀå ºÐ¼®°ú ¿¹Ãø : ¹æ¹ýº°

  • ¼­·Ð°ú Á¤ÀÇ
  • ÁÖ¿ä Á¶»ç °á°ú/¹ßÀü
  • ½ÃÀå ¸ÅÃâ ¿¹Ãø : ¹æ¹ýº°, 2017³â-2031³â
    • In Vivo Method
    • In Vitro Method
    • In Silico Method
  • ½ÃÀåÀÇ ¸Å·Â : ¹æ¹ýº°

Á¦7Àå ½ÃÀå ºÐ¼®°ú ¿¹Ãø : »ê¾÷ À¯Çüº°

  • ¼­·Ð°ú Á¤ÀÇ
  • ÁÖ¿ä Á¶»ç °á°ú/¹ßÀü
  • ½ÃÀå ¸ÅÃâ ¿¹Ãø : »ê¾÷ À¯Çüº°, 2017³â-2031³â
    • ÀǾàǰ ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö
    • È­Àåǰ
    • È­ÇÐ
    • ÀÇ·á±â±â
    • ±âŸ(½Äǰ, ³ó¾÷, ȯ°æ)
  • ½ÃÀåÀÇ ¸Å·Â : »ê¾÷ À¯Çüº°

Á¦8Àå ¼¼°è ½ÃÀå ºÐ¼®°ú ¿¹Ãø : Áö¿ªº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ½ÃÀå ¸ÅÃâ ¿¹Ãø : Áö¿ªº°, 2017³â-2031³â
    • ºÏ¹Ì
    • À¯·´
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ½ÃÀåÀÇ ¸Å·Â : Áö¿ªº°

Á¦9Àå ºÏ¹Ì ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦10Àå À¯·´ ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦12Àå ¶óÆ¾¾Æ¸Þ¸®Ä« ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦13Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦14Àå °æÀï ±¸µµ

  • ½ÃÀå °æÀï ¸ÅÆ®¸¯½º(±â¾÷ Tierº°¡¤±â¾÷ ±Ô¸ðº°)
  • ½ÃÀå Á¡À¯À² ºÐ¼® : ±â¾÷º°(2022³â)
  • ±â¾÷ °³¿ä
    • Laboratory Corporation of America Holdings
    • Charles River Laboratories, Inc.
    • Eurofins Scientific
    • Bureau Veritas
    • Envigo
    • Evotec AG
    • Merck KGaA
    • SGS Group
    • Pharmaceutical Product Development, LLC
    • Wuxi AppTec
LSH 24.04.25

Toxicology Testing Services Market - Scope of Report

TMR's report on the global toxicology testing services market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global toxicology testing services market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global toxicology testing services market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the toxicology testing services market.

Market Snapshot
Market Value in 2022US$ 34.7 Bn
Market Value in 2031US$ 55.7 Bn
CAGR5.5%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global toxicology testing services market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global toxicology testing services market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global toxicology testing services market.

The report delves into the competitive landscape of the global toxicology testing services market. Key players operating in the global toxicology testing services market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global toxicology testing services market profiled in this report.

Key Questions Answered in Global toxicology testing services Market Report:

  • What is the sales/revenue generated by toxicology testing services across all regions during the forecast period?
  • What are the opportunities in the global toxicology testing services market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Toxicology Testing Services Market - Research Objectives and Research Approach

The comprehensive report on the global toxicology testing services market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global toxicology testing services market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global toxicology testing services market.

Table of Contents

1. Executive Summary

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Toxicology Testing Services Market

4. Market Overview

  • 4.1. Market Segmentation
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Toxicology Testing Services Market Analysis and Forecast, 2022-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. List of Types of Toxicology Testing Services Tests
  • 5.3. Disease Prevalence & Incidence Rate Globally with Key Countries
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Toxicology Testing Services Market Analysis and Forecast, by Method

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Method, 2017-2031
    • 6.3.1. In Vivo Method
    • 6.3.2. In Vitro Method
    • 6.3.3. In Silico Method
  • 6.4. Market Attractiveness, by Method

7. Toxicology Testing Services Market Analysis and Forecast, by Type of Industry

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Type of Industry, 2017-2031
    • 7.3.1. Pharmaceutical & Biotechnology
    • 7.3.2. Cosmetic
    • 7.3.3. Chemical
    • 7.3.4. Medical Devices
    • 7.3.5. Others (Food, Agricultural, and Environmental)
  • 7.4. Market Attractiveness, by Type of Industry

8. Global Toxicology Testing Services Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region, 2017-2031
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness, by Region

9. North America Toxicology Testing Services Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by Method, 2017-2031
    • 9.2.1. In Vivo Method
    • 9.2.2. In Vitro Method
    • 9.2.3. In Silico Method
  • 9.3. Market Attractiveness, by Method
  • 9.4. Market Value Forecast, by Type of Industry, 2017-2031
    • 9.4.1. Pharmaceutical & Biotechnology
    • 9.4.2. Cosmetic
    • 9.4.3. Chemical
    • 9.4.4. Medical Devices
    • 9.4.5. Others (Food, Agricultural, and Environmental)
  • 9.5. Market Attractiveness, by Type of Industry
  • 9.6. Market Value Forecast, by Country, 2022-2031
    • 9.6.1. U.S.
    • 9.6.2. Canada
  • 9.7. Market Attractiveness Analysis
    • 9.7.1. By Method
    • 9.7.2. By Type of Industry
    • 9.7.3. By Country

10. Europe Toxicology Testing Services Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Method, 2017-2031
    • 10.2.1. In Vivo Method
    • 10.2.2. In Vitro Method
    • 10.2.3. In Silico Method
  • 10.3. Market Attractiveness, by Method
  • 10.4. Market Value Forecast, by Type of Industry, 2017-2031
    • 10.4.1. Pharmaceutical & Biotechnology
    • 10.4.2. Cosmetic
    • 10.4.3. Chemical
    • 10.4.4. Medical Devices
    • 10.4.5. Others (Food, Agricultural, and Environmental)
  • 10.5. Market Attractiveness, by Type of Industry
  • 10.6. Market Value Forecast, by Country/Sub-region, 2022-2031
    • 10.6.1. Germany
    • 10.6.2. U.K.
    • 10.6.3. France
    • 10.6.4. Italy
    • 10.6.5. Spain
    • 10.6.6. Rest of Europe
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Method
    • 10.7.2. By Type of Industry
    • 10.7.3. By Country/Sub-region

11. Asia Pacific Toxicology Testing Services Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Method, 2017-2031
    • 11.2.1. In Vivo Method
    • 11.2.2. In Vitro Method
    • 11.2.3. In Silico Method
  • 11.3. Market Attractiveness, by Method
  • 11.4. Market Value Forecast, by Type of Industry, 2017-2031
    • 11.4.1. Pharmaceutical & Biotechnology
    • 11.4.2. Cosmetic
    • 11.4.3. Chemical
    • 11.4.4. Medical Devices
    • 11.4.5. Others (Food, Agricultural, and Environmental)
  • 11.5. Market Attractiveness, by Type of Industry
  • 11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.6.1. China
    • 11.6.2. Japan
    • 11.6.3. India
    • 11.6.4. Australia & New Zealand
    • 11.6.5. Rest of Asia Pacific
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Method
      • 11.7.1.1. By Type of Industry
      • 11.7.1.2. By Country/Sub-region

12. Latin America Toxicology Testing Services Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Method, 2017-2031
    • 12.2.1. In Vivo Method
    • 12.2.2. In Vitro Method
    • 12.2.3. In Silico Method
  • 12.3. Market Attractiveness, by Method
  • 12.4. Market Value Forecast, by Type of Industry, 2017-2031
    • 12.4.1. Pharmaceutical & Biotechnology
    • 12.4.2. Cosmetic
    • 12.4.3. Chemical
    • 12.4.4. Medical Devices
    • 12.4.5. Others (Food, Agricultural, and Environmental)
  • 12.5. Market Attractiveness, by Type of Industry
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. Brazil
    • 12.6.2. Mexico
    • 12.6.3. Rest of Latin America
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Method
      • 12.7.1.1. By Type of Industry
      • 12.7.1.2. By Country/Sub-region

13. Middle East & Africa Toxicology Testing Services Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Method, 2017-2031
    • 13.2.1. In Vivo Method
    • 13.2.2. In Vitro Method
    • 13.2.3. In Silico Method
  • 13.3. Market Attractiveness, by Method
  • 13.4. Market Value Forecast, by Type of Industry, 2017-2031
    • 13.4.1. Pharmaceutical & Biotechnology
    • 13.4.2. Cosmetic
    • 13.4.3. Chemical
    • 13.4.4. Medical Devices
    • 13.4.5. Others (Food, Agricultural, and Environmental)
  • 13.5. Market Attractiveness, by Type of Industry
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. GCC Countries
    • 13.6.2. South Africa
    • 13.6.3. Rest of Middle East & Africa
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Method
    • 13.7.2. By Type of Industry
    • 13.7.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 14.2. Market Share Analysis, by Company (2022)
  • 14.3. Company Profiles
    • 14.3.1. Laboratory Corporation of America Holdings
      • 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.1.2. Method Portfolio
      • 14.3.1.3. Financial Overview
      • 14.3.1.4. SWOT Analysis
      • 14.3.1.5. Strategic Overview
    • 14.3.2. Charles River Laboratories, Inc.
      • 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.2.2. Method Portfolio
      • 14.3.2.3. Financial Overview
      • 14.3.2.4. SWOT Analysis
      • 14.3.2.5. Strategic Overview
    • 14.3.3. Eurofins Scientific
      • 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.3.2. Method Portfolio
      • 14.3.3.3. Financial Overview
      • 14.3.3.4. SWOT Analysis
      • 14.3.3.5. Strategic Overview
    • 14.3.4. Bureau Veritas
      • 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.4.2. Method Portfolio
      • 14.3.4.3. Financial Overview
      • 14.3.4.4. SWOT Analysis
      • 14.3.4.5. Strategic Overview
    • 14.3.5. Envigo
      • 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.5.2. Method Portfolio
      • 14.3.5.3. Financial Overview
      • 14.3.5.4. SWOT Analysis
      • 14.3.5.5. Strategic Overview
    • 14.3.6. Evotec AG
      • 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.6.2. Method Portfolio
      • 14.3.6.3. Financial Overview
      • 14.3.6.4. SWOT Analysis
      • 14.3.6.5. Strategic Overview
    • 14.3.7. Merck KGaA
      • 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.7.2. Method Portfolio
      • 14.3.7.3. Financial Overview
      • 14.3.7.4. SWOT Analysis
      • 14.3.7.5. Strategic Overview
    • 14.3.8. SGS Group
      • 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.8.2. Method Portfolio
      • 14.3.8.3. Financial Overview
      • 14.3.8.4. SWOT Analysis
      • 14.3.8.5. Strategic Overview
    • 14.3.9. Pharmaceutical Product Development, LLC
      • 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.9.2. Method Portfolio
      • 14.3.9.3. Financial Overview
      • 14.3.9.4. SWOT Analysis
      • 14.3.9.5. Strategic Overview
    • 14.3.10. Wuxi AppTec
      • 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.10.2. Method Portfolio
      • 14.3.10.3. Financial Overview
      • 14.3.10.4. SWOT Analysis
      • 14.3.10.5. Strategic Overview
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦